PEP/NEWS — Peptide intel. Daily.

KISSPEPTIN NEURONS SHOW PROLONGED SURGE ACTIVITY UP TO 12 HOURS BEFORE OVULATION IN MICEAPOE2 CARRIERS HAVE SIGNIFICANTLY LOWER RATES OF NEURONAL SENESCENCE VERSUS APOE4DASATINIB + QUERCETIN SENOLYTIC COMBO CAUSED MYELIN DAMAGE IN SPECIFIC MOUSE BRAIN REGIONSCREATINE SUPPLEMENTATION ADDED MEASURABLE MUSCLE POWER BENEFIT ON TOP OF EXERCISE IN OLDER ADULTSIGF-1 RECEPTOR INHIBITION EXTENDED MEDIAN LIFESPAN IN MULTIPLE MOUSE MODEL LINEST CELLS MAY RETAIN PRO-INFLAMMATORY PHENOTYPE FOR YEARS AFTER OBESITY IS RESOLVEDSITTING 11+ HOURS PER DAY ASSOCIATED WITH 48% INCREASED MORTALITY RISK IN LARGE COUNTY-LEVEL DATASETRETATRUTIDE TARGETS THREE METABOLIC RECEPTORS SIMULTANEOUSLY: GLP-1, GIP, AND GLUCAGON KISSPEPTIN NEURONS SHOW PROLONGED SURGE ACTIVITY UP TO 12 HOURS BEFORE OVULATION IN MICEAPOE2 CARRIERS HAVE SIGNIFICANTLY LOWER RATES OF NEURONAL SENESCENCE VERSUS APOE4DASATINIB + QUERCETIN SENOLYTIC COMBO CAUSED MYELIN DAMAGE IN SPECIFIC MOUSE BRAIN REGIONSCREATINE SUPPLEMENTATION ADDED MEASURABLE MUSCLE POWER BENEFIT ON TOP OF EXERCISE IN OLDER ADULTSIGF-1 RECEPTOR INHIBITION EXTENDED MEDIAN LIFESPAN IN MULTIPLE MOUSE MODEL LINEST CELLS MAY RETAIN PRO-INFLAMMATORY PHENOTYPE FOR YEARS AFTER OBESITY IS RESOLVEDSITTING 11+ HOURS PER DAY ASSOCIATED WITH 48% INCREASED MORTALITY RISK IN LARGE COUNTY-LEVEL DATASETRETATRUTIDE TARGETS THREE METABOLIC RECEPTORS SIMULTANEOUSLY: GLP-1, GIP, AND GLUCAGON

Last updated May 10, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · Peter Attia
PETER ATTIA GOES DEEP ON PEPTIDE SCIENCE: SEPARATING SIGNAL FROM HYPE...

*Attia's AMA #83 calls peptides a legitimate drug class — but warns the evidence base is narrow.*

Peter Attia

Featured Briefs

▶ Video · Peptide-anchored

STOP AGING: THE DOCTOR’S RETATRUTIDE & NAD+ PROTOCOL. SHE IS OVER 60, LOOKS 30?

Welcome to the ultimate resource for Longevity, Hormone Optimization, and Biohacking, led by a Mayo Clinic Trained Family Physician. I'm here to cut through the noise and provide evidence-based strategies for extending your healthspan and d

Doctor Michael Mueller
▶ Video · Peptide-anchored

BPC-157 DOES NOT CAUSE CANCER (DOCTOR REACTS)

Shawn Ryan Show Pod link: https://www.youtube.com/watch?v=y4ATx9A9y6w BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and

Dr Alex Tatem

More Headlines